TAM
IMMX icon

Tocqueville Asset Management’s Immix Biopharma IMMX Stock Holding History

Tocqueville Asset Management’s Portfolio IMMX Stock Details IMMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$816K Buy
89,550
+21,000
+31% +$154K 0.01% 384
2025
Q4 		$359K Buy
68,550
+28,300
+70% +$116K 0.01% 492
2025
Q3 		$84.1K Buy
40,250
+10,950
+37% +$26.3K ﹤0.01% 545
2025
Q2 		$60.7K Hold
29,300
– – ﹤0.01% 533
2025
Q1 		$49.2K Sell
29,300
-9,000
-23% -$17K ﹤0.01% 510
2024
Q4 		$84.3K Sell
38,300
-5,000
-12% -$9.13K ﹤0.01% 534
2024
Q3 		$64.5K Buy
43,300
+5,500
+15% +$11.1K ﹤0.01% 521
2024
Q2 		$74.8K Hold
37,800
– – ﹤0.01% 518
2024
Q1 		$116K Buy
37,800
+17,800
+89% +$68.9K ﹤0.01% 523
2023
Q4 		$138K Buy
20,000
+8,000
+67% +$36.2K ﹤0.01% 501
2023
Q3 		$41K Buy
+12,000
New +$28.1K ﹤0.01% 506

Other funds holding IMMX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return

Tocqueville Asset Management's IMMX Position: Q1 2026 in Review

Tocqueville Asset Management increased its Immix Biopharma (IMMX) stake by 31% in Q1 2026, buying an estimated $154K and bringing the position to 89,550 shares worth $816K. The position accounts for 0.01% of the portfolio, ranked #384.

Tocqueville Asset Management first reported a position in IMMX in Q3 2023 and has held it in 11 quarters since. 77 funds tracked by Wall St. Rank hold IMMX as of Q1 2026.

  • Tocqueville Asset Management held 89,550 shares of Immix Biopharma worth $816K as of Q1 2026.
  • Tocqueville Asset Management bought 21,000 Immix Biopharma shares in Q1 2026, an estimated $154K.
  • Immix Biopharma made up 0.01% of Tocqueville Asset Management's portfolio in Q1 2026, its #384 holding.
  • Tocqueville Asset Management first reported a position in Immix Biopharma in Q3 2023 and has held it in 11 quarters since.
  • 77 funds tracked by Wall St. Rank held Immix Biopharma as of Q1 2026.

Based on Tocqueville Asset Management's 13F filing for Q1 2026, filed 12 May 2026.